BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 33094535)

  • 1. Competing-risks model for prediction of small-for-gestational-age neonate from biophysical and biochemical markers at 11-13 weeks' gestation.
    Papastefanou I; Wright D; Syngelaki A; Souretis K; Chrysanthopoulou E; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):52-61. PubMed ID: 33094535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competing-risks model for prediction of small-for-gestational-age neonate from maternal characteristics, serum pregnancy-associated plasma protein-A and placental growth factor at 11-13 weeks' gestation.
    Papastefanou I; Wright D; Lolos M; Anampousi K; Mamalis M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Mar; 57(3):392-400. PubMed ID: 32936500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-trimester contingent screening for small-for-gestational-age neonate.
    Nowacka U; Papastefanou I; Bouariu A; Syngelaki A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):177-184. PubMed ID: 34214232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competing risks model for prediction of small-for-gestational-age neonates from biophysical markers at 19 to 24 weeks' gestation.
    Papastefanou I; Nowacka U; Syngelaki A; Mansukhani T; Karamanis G; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2021 Nov; 225(5):530.e1-530.e19. PubMed ID: 33901487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competing-risks model for prediction of small-for-gestational-age neonate from estimated fetal weight at 19-24 weeks' gestation.
    Papastefanou I; Nowacka U; Syngelaki A; Dragoi V; Karamanis G; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Jun; 57(6):917-924. PubMed ID: 33464642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competing-risks model for prediction of small-for-gestational-age neonate from maternal characteristics and medical history.
    Papastefanou I; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Aug; 56(2):196-205. PubMed ID: 32573831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competing-risks model for prediction of small-for-gestational-age neonate at 36 weeks' gestation.
    Papastefanou I; Thanopoulou V; Dimopoulou S; Syngelaki A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2022 Nov; 60(5):612-619. PubMed ID: 36056735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competing-risks model for prediction of small-for-gestational-age neonate from maternal characteristics and serum pregnancy-associated plasma protein-A at 11-13 weeks' gestation.
    Papastefanou I; Wright D; Syngelaki A; Lolos M; Anampousi K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Oct; 56(4):541-548. PubMed ID: 32770776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.
    Bakalis S; Peeva G; Gonzalez R; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):446-51. PubMed ID: 25826154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stratification of pregnancy care based on risk of pre-eclampsia derived from uterine artery Doppler at 19-24 weeks' gestation.
    Litwinska M; Litwinska E; Lisnere K; Syngelaki A; Wright A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Jul; 58(1):67-76. PubMed ID: 33645854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of competing-risks model with angiogenic factors in midgestation screening for preterm growth-related neonatal morbidity.
    Papastefanou I; Menenez M; Szczepkowska A; Gungil B; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2024 May; 63(5):613-618. PubMed ID: 38057964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11-13 weeks' gestation: data from EVENTS trial.
    Benkő Z; Wright A; Rehal A; Cimpoca B; Syngelaki A; Delgado JL; Tsokaki T; De Alvarado M; Vojtassakova D; Malligiannis Ntalianis K; Chaveeva P; Del Campo A; De Ganzo T; Resta C; Atanasova V; Accurti V; Villalain C; Aguilera J; Dojcinovska D; O'Gorman N; Plasencia W; Zingler E; Dutemeyer V; Alvar B; Casanova MC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Feb; 57(2):257-265. PubMed ID: 33142361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35-37 weeks' gestation.
    Ciobanu A; Rouvali A; Syngelaki A; Akolekar R; Nicolaides KH
    Am J Obstet Gynecol; 2019 May; 220(5):486.e1-486.e11. PubMed ID: 30707967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of screening performance of first-trimester competing-risks prediction model for small-for-gestational age in Asian population.
    Nguyen-Hoang L; Papastefanou I; Sahota DS; Pooh RK; Zheng M; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Yapan P; Sim WS; Poon LC;
    Ultrasound Obstet Gynecol; 2024 Mar; 63(3):331-341. PubMed ID: 37552550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stratification of pregnancy care based on risk of pre-eclampsia derived from biophysical and biochemical markers at 19-24 weeks' gestation.
    Litwinska M; Litwinska E; Astudillo A; Syngelaki A; Wright A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Sep; 58(3):360-368. PubMed ID: 33794058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 19-24 weeks.
    Poon LC; Lesmes C; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):437-45. PubMed ID: 25988293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China.
    Hu J; Gao J; Liu J; Meng H; Hao N; Song Y; Ma L; Luo W; Sun J; Gao W; Meng W; Sun Y
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):529-539. PubMed ID: 33817865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre-eclampsia at 19-23 weeks' gestation.
    Sapantzoglou I; Wright A; Arozena MG; Campos RV; Charakida M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):75-83. PubMed ID: 33142353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.